Canada okays 'liberation therapy' trials

June 29, 2011

Canada will fund clinical trials for a controversial multiple sclerosis treatment that targets blocked neck veins, Health Minister Leona Aglukkaq announced Wednesday.

"Patients and their families have been calling for funding of a clinical trial on a treatment to unblock veins," the minister said in the foyer of the House of Commons.

"Our government had been clear that we are prepared to fund a clinical trial but only when there was sufficient medical to support proceeding safely."

She said a scientific working group established by the government last August recommended proceeding with the trials after reviewing seven ongoing studies looking at "chronic cerebrospinal venous insufficiency" and its link to MS.

The Canadian Institute of Health Research plans to establish terms for the clinical trial. Afterward, the government will launch a call for applications to conduct the trials.

MS is an autoimmune disease that affects the brain and spinal cord, impairing vision and speech and muscle control, leading to tremors, spasms and chronic pain.

Italian researcher Paolo Zamboni theorized in 2008 that it could be reversed by unblocking neck veins using .

According to his theory, malformed blood vessels caused increased iron deposits in the brain that triggered the .

Many Canadian have sought the so-called "liberation treatment" abroad, as it is not offered in Canada. Some reported vast improvements in their mobility while others experienced little or no alleviation of symptoms.

Related Stories

Recommended for you

Drug found that induces apoptosis in myofibroblasts reducing fibrosis in scleroderma

December 15, 2017
(Medical Xpress)—An international team of researchers has found that the drug navitoclax can induce apoptosis (self-destruction) in myofibroblasts in mice, reducing the spread of fibrosis in scleroderma. In their paper ...

How defeating THOR could bring a hammer down on cancer

December 14, 2017
It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

Researchers track muscle stem cell dynamics in response to injury and aging

December 14, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) describes the biology behind why muscle stem cells respond differently to aging or injury. The findings, published in Cell Stem Cell, ...

'Human chronobiome' study informs timing of drug delivery, precision medicine approaches

December 13, 2017
Symptoms and efficacy of medications—and indeed, many aspects of the human body itself—vary by time of day. Physicians tell patients to take their statins at bedtime because the related liver enzymes are more active during ...

Study confirms link between the number of older brothers and increased odds of being homosexual

December 12, 2017
Groundbreaking research led by a team from Brock University has further confirmed that sexual orientation for men is likely determined in the womb.

Potassium is critical to circadian rhythms in human red blood cells

December 12, 2017
An innovative new study from the University of Surrey and Cambridge's MRC Laboratory of Molecular Biology, published in the prestigious journal Nature Communications, has uncovered the secrets of the circadian rhythms in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.